Other
Periodontal Diseases
0
Pipeline Programs↗
8
Active Trials↗
1
Companies Involved↗
Periodontal Diseases is an early-stage landscape with 0 programs across 1 company. The most active players are Dongkook Pharmaceutical Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
19
clinical trials
Completed9 · 47%
Not yet recruiting4 · 21%
Recruiting4 · 21%
Unknown status2 · 11%
Clinical Trials
Trial Activity
19 trials
Evaluation of the Effect of Hyperuricemia on Alveolar Bone Loss and Oxidative Stress
Recruiting·Recep Tayyip Erdogan University Training and Research Hospital·N/A·NCT07666126·80 enrolled
Oral and Systemic Levels of TFF-1 and TTF-3 in Periodontal Diseases
Completed·—·N/A·NCT04407026·100 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)